The World Vaccine Congress Washington 2025, 21-24 April 2025, delivered another landmark year, bringing together more than 4,000 global stakeholders from biotechnology, pharmaceuticals, government, academia and the broader global health ecosystem. The event reinforced its standing as an influential and collaborative forum in ...

We are delighted to announce that Dr. Ikechukwu Benjamin Moses has joined the touchINFECTIOUS DISEASES Editorial Board! “I strongly believe that this platform will greatly contribute in promoting science to a broader audience with strong societal impact.” Dr Moses brings ...

The ESCMID Global Congress 2025 brought together world-leading researchers and clinicians to present practice-changing updates in infectious disease management. This article distils five critical insights from interviews and landmark trial results, covering innovations in antimicrobial therapy, fungal infections, resistance surveillance and ...

In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.

Dr Tony Bai, ESCMID Global 2025 Young Investigator Award winner, discusses his research on bacterial infections, antibiotic regimens, and his journey balancing clinical work, research, and family life.

The American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) has introduced a new groundbreaking set of guidelines to enhance infection prevention in regional anesthesia and interventional pain medicine procedures. Developed over four years, these recommendations address infection ...

Prof. Torres discusses the evolution of pneumococcal disease and the impact of novel vaccination strategies.

In this episode, we explore how point-of-care testing is transforming the management of sexually transmitted infections (STIs). Joined by Dr Libby van Gerwen, we discuss the rising global STI rates and the role these innovative tests play in addressing the issue. We also explore the challenges current point-of-care tests face and how next-generation advancements could further transform the future of STI diagnosis and treatment.

Article highlights Erythrasma is a common chronic superficial cutaneous bacterial infection caused by Corynebacterium minutissimum when conditions are conducive. Corynebacterium minutissimum produces coproporphyrin III (a phosphor) that emits a coral pink fluorescence under Wood’s lamp and helps confirm the ...